Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Confirmation statement made on 2026-06-11 with no updates
Registration of charge 102275840002, created on 2026-03-11
Appointment of Adam David George as a director on 2025-11-30
Termination of appointment of Cosmo Birdie Feilding Mellen as a director on 2025-10-24
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
30/09/2026Filing deadline
Confirms the registry record is up to date
The latest figures ELEUSIS THERAPEUTICS LTD filed. Okredo holds filed accounts data for 2022–2024; the year-by-year record is on the financials page.
Net Assets
2023: £-9.14M
Total Assets
2023: £2.44M
Cash in Bank
2023: £14.97K
Total Liabilities
2023: £11.58M
Employees
2023: 7
Of the 4 measures with an earlier filing to compare against, 2 rose and 2 fell. Net assets moved furthest, down 21.23% on 2023. See the full financial analysis for ELEUSIS THERAPEUTICS LTD.
The full financial record
Four ways through ELEUSIS THERAPEUTICS LTD's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2022–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 5 | -2 |
| 2023 | 7 | +3 |
| 2022 | 4 | – |
Reported employee count increased from 4 in 2022 to 5 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 12/06/2016–03/01/2024 | 2 | |
| Director | 20/10/2022–Present | 39 | |
| Director | 30/11/2025–Present | 24 | |
| Director | 20/10/2017–20/10/2022 | 13 | |
| Director | 20/10/2022–24/10/2025 | 9 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 01/06/2020–Present | 0 |
Every document on the Companies House record, newest first.
Confirmation statement made on 2026-06-11 with no updates
Registration of charge 102275840002, created on 2026-03-11
Appointment of Adam David George as a director on 2025-11-30
Termination of appointment of Cosmo Birdie Feilding Mellen as a director on 2025-10-24
Total exemption full accounts made up to 2024-12-31
Confirmation statement made on 2025-06-11 with no updates
Total exemption full accounts made up to 2023-12-31
Confirmation statement made on 2024-06-11 with updates
Termination of appointment of Shlomi Raz as a director on 2024-01-03
Total exemption full accounts made up to 2022-12-31
Confirmation statement made on 2023-06-11 with no updates
Registered office address changed from 83 Cambridge Street Pimlico London SW1V 4PS United Kingdom to 6th Floor 25 Farringdon Street London EC4A 4AB on 2023-05-31
Showing 12 of 19 filings
See when the next accounts and confirmation statement are due
84 UK companies are similar to ELEUSIS THERAPEUTICS LTD, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB
Allia Future Business Centre, Kings Hedges Road, Cambridge CB4 2HY
The Lexicon Second Floor, Mount Street, Manchester M2 5NT
Spitfire House 19 Falcon Court, Preston Farm Industrial Estate, Stockton-On-Tees TS18 3TU
76 Portland Place, London W1B 1NT
A short description of the company, written from its Companies House record.
ELEUSIS THERAPEUTICS LTD is a private limited company registered in the United Kingdom, based in 6th Floor 25 Farringdon Street, London EC4A 4AB. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 10 years 3 months.
The register currently records it as active. Its 2024 accounts report net assets of £-11.08M and 5 employees.
Answered from this company's own registry record and filed figures.
Companies House records ELEUSIS THERAPEUTICS LTD under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
ELEUSIS THERAPEUTICS LTD is recorded as active on the Companies House register, and has been on it since 12/06/2016.
The most recent accounts Okredo holds cover 2024 and report net assets of £-11.08M, total assets of £1.82M, cash in bank of £69.56K and total liabilities of £12.89M.
The most recent document on the record is dated 19/07/2026: Confirmation statement made on 2026-06-11 with no updates, 2 months ago.
On the current registry record, accounts are due by 30/09/2026.
Companies House lists 5 officers (2 currently in post) and 1 person with significant control.